Granite Group Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.58M Sell
29,946
-4,852
-14% -$428K 1.63% 9
2026
Q2
$2.72M Buy
34,798
+3,251
+10% +$262K 1.61% 18
2026
Q1
$2.73M Buy
31,547
+2,778
+10% +$266K 1.65% 18
2025
Q4
$2.76M Buy
28,769
+309
+1% +$30K 1.57% 15
2025
Q3
$2.71M Buy
28,460
+6
+0% +$552 1.64% 12
2025
Q2
$2.48M Buy
28,454
+386
+1% +$32.7K 1.49% 15
2025
Q1
$2.52M Sell
28,068
-248
-0.9% -$22.2K 1.75% 11
2024
Q4
$2.26M Buy
28,316
+1,097
+4% +$95K 1.44% 17
2024
Q3
$2.45M Sell
27,219
-446
-2% -$37.5K 1.57% 14
2024
Q2
$2.18M Buy
27,665
+1,224
+5% +$100K 1.65% 13
2024
Q1
$2.3M Sell
26,441
-49
-0.2% -$4.18K 1.55% 11
2023
Q4
$2.26M Buy
+26,490
New +$2.02M 1.6% 13

Other funds holding MDT

Granite Group Advisors's MDT Position: Q3 2026 in Review

Granite Group Advisors reduced its Medtronic (MDT) stake by 14% in Q3 2026, selling an estimated $428K and leaving 29,946 shares worth $2.58M. The position accounts for 1.63% of the portfolio, ranked #9.

Granite Group Advisors first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.76M in Q4 2025. 1,360 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Granite Group Advisors held 29,946 shares of Medtronic worth $2.58M as of Q3 2026.
  • Granite Group Advisors sold 4,852 Medtronic shares in Q3 2026, an estimated $428K.
  • Medtronic made up 1.63% of Granite Group Advisors's portfolio in Q3 2026, its #9 holding.
  • Granite Group Advisors first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Granite Group Advisors's Medtronic position peaked at $2.76M in Q4 2025.
  • 1,360 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Granite Group Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.